ATE325120T1 - Neue verwendung substituierter aminomethylchromane - Google Patents
Neue verwendung substituierter aminomethylchromaneInfo
- Publication number
- ATE325120T1 ATE325120T1 AT02767363T AT02767363T ATE325120T1 AT E325120 T1 ATE325120 T1 AT E325120T1 AT 02767363 T AT02767363 T AT 02767363T AT 02767363 T AT02767363 T AT 02767363T AT E325120 T1 ATE325120 T1 AT E325120T1
- Authority
- AT
- Austria
- Prior art keywords
- new use
- substituted aminomethyl
- chromanes
- aminomethyl chromanes
- substituted
- Prior art date
Links
- -1 AMINOMETHYL CHROMANES Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01122377 | 2001-09-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE325120T1 true ATE325120T1 (de) | 2006-06-15 |
Family
ID=8178662
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02767363T ATE325120T1 (de) | 2001-09-19 | 2002-08-12 | Neue verwendung substituierter aminomethylchromane |
Country Status (25)
Country | Link |
---|---|
US (1) | US7618988B2 (de) |
EP (1) | EP1427724B1 (de) |
JP (1) | JP4615857B2 (de) |
KR (1) | KR100912911B1 (de) |
CN (1) | CN100338060C (de) |
AR (1) | AR036677A1 (de) |
AT (1) | ATE325120T1 (de) |
AU (1) | AU2002331229B2 (de) |
BR (1) | BR0212555A (de) |
CA (1) | CA2460696C (de) |
CY (1) | CY1105118T1 (de) |
DE (1) | DE60211186T2 (de) |
DK (1) | DK1427724T3 (de) |
ES (1) | ES2262840T3 (de) |
HU (1) | HUP0401910A3 (de) |
MX (1) | MXPA04002492A (de) |
MY (1) | MY128882A (de) |
PE (1) | PE20030428A1 (de) |
PL (1) | PL208787B1 (de) |
PT (1) | PT1427724E (de) |
RU (1) | RU2322443C2 (de) |
SI (1) | SI1427724T1 (de) |
TW (1) | TWI244391B (de) |
WO (1) | WO2003024960A1 (de) |
ZA (1) | ZA200402855B (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10318690B3 (de) * | 2003-04-24 | 2004-11-11 | Merck Patent Gmbh | Verfahren zur Herstellung von Nicotinaldehyden |
FR2978916B1 (fr) | 2011-08-10 | 2013-07-26 | Servier Lab | Composition pharmaceutique solide pour administration buccale d'agomelatine |
HUE037732T2 (hu) * | 2012-04-18 | 2018-09-28 | Contera Pharma Aps | A mozgászavarok fejlett kezelésére alkalmas, szájon át szedhetõ gyógyszerészeti készítmény |
FR3001894A1 (fr) | 2013-02-08 | 2014-08-15 | Servier Lab | Composition pharmaceutique solide pour administration buccale d'agomelatine |
WO2018011181A1 (en) | 2016-07-11 | 2018-01-18 | Contera Pharma Aps | Pulsatile drug delivery system for treating morning akinesia |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5767132A (en) * | 1980-10-07 | 1982-04-23 | Nippon Steel Corp | Vertical type continuous annealing furnace having independently moving middle partition plate |
DE4135474A1 (de) * | 1991-10-28 | 1993-04-29 | Bayer Ag | 2-aminomethyl-chromane |
SI9300097B (en) * | 1992-02-27 | 2001-12-31 | Janssen Pharmaceutica Nv | (benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines |
RU2129556C1 (ru) * | 1993-08-19 | 1999-04-27 | Жансен Фармасетика Н.В. | Производное дигидробензопирана, обладающее сосудосуживающим действием, промежуточные соединения, способы получения, фармацевтическая композиция и способ ее получения |
PT707007E (pt) * | 1994-10-14 | 2002-06-28 | Merck Patent Gmbh | Derivados amino(tio)eter como agentes activos no snc |
US5585388A (en) * | 1995-04-07 | 1996-12-17 | Sibia Neurosciences, Inc. | Substituted pyridines useful as modulators of acetylcholine receptors |
US5756521A (en) * | 1996-04-03 | 1998-05-26 | American Home Products Corporation | Chroman-2-ylmethylamino derivatives |
UA73981C2 (en) * | 2000-03-10 | 2005-10-17 | Merck Patent Gmbh | (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit |
-
2002
- 2002-08-12 CN CNB028183266A patent/CN100338060C/zh not_active Expired - Fee Related
- 2002-08-12 DK DK02767363T patent/DK1427724T3/da active
- 2002-08-12 CA CA2460696A patent/CA2460696C/en not_active Expired - Fee Related
- 2002-08-12 ES ES02767363T patent/ES2262840T3/es not_active Expired - Lifetime
- 2002-08-12 BR BR0212555-2A patent/BR0212555A/pt not_active IP Right Cessation
- 2002-08-12 WO PCT/EP2002/009001 patent/WO2003024960A1/en active IP Right Grant
- 2002-08-12 KR KR1020047002484A patent/KR100912911B1/ko not_active IP Right Cessation
- 2002-08-12 MX MXPA04002492A patent/MXPA04002492A/es active IP Right Grant
- 2002-08-12 EP EP02767363A patent/EP1427724B1/de not_active Expired - Lifetime
- 2002-08-12 JP JP2003528807A patent/JP4615857B2/ja not_active Expired - Fee Related
- 2002-08-12 PL PL369684A patent/PL208787B1/pl not_active IP Right Cessation
- 2002-08-12 AT AT02767363T patent/ATE325120T1/de active
- 2002-08-12 AU AU2002331229A patent/AU2002331229B2/en not_active Ceased
- 2002-08-12 PT PT02767363T patent/PT1427724E/pt unknown
- 2002-08-12 RU RU2004112190/15A patent/RU2322443C2/ru not_active IP Right Cessation
- 2002-08-12 US US10/489,960 patent/US7618988B2/en not_active Expired - Fee Related
- 2002-08-12 DE DE60211186T patent/DE60211186T2/de not_active Expired - Lifetime
- 2002-08-12 SI SI200230351T patent/SI1427724T1/sl unknown
- 2002-08-12 HU HU0401910A patent/HUP0401910A3/hu unknown
- 2002-08-13 TW TW091118183A patent/TWI244391B/zh not_active IP Right Cessation
- 2002-09-16 MY MYPI20023438A patent/MY128882A/en unknown
- 2002-09-17 PE PE2002000915A patent/PE20030428A1/es not_active Application Discontinuation
- 2002-09-18 AR ARP020103509A patent/AR036677A1/es unknown
-
2004
- 2004-04-15 ZA ZA200402855A patent/ZA200402855B/en unknown
-
2006
- 2006-07-28 CY CY20061101061T patent/CY1105118T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE319730T1 (de) | Neue kristallforme von azithromycin | |
DE60236226D1 (de) | Verbesserung der Altersweitsichtigkeit | |
DK1360169T3 (da) | Succinatsalt af O-desmethyl-venlafaxin | |
DE50212455D1 (de) | Verwendung von Dimerdiolen | |
NO20041689L (no) | Substituerte tioacetamider | |
DE02784674T1 (de) | Quantifizierung von polypeptiden | |
DE60120514D1 (de) | Plektrum | |
DK1373228T3 (da) | Substituerede fluoralkoxyphenylsulfonylurinstoffer | |
ATE325120T1 (de) | Neue verwendung substituierter aminomethylchromane | |
IS6884A (is) | Aðferðir við að nýta líffræðilegan fjölbreytileika | |
IS6888A (is) | Aðferð við meðferð sykursýki af gerð I | |
DE60208824D1 (de) | Verbesserungen von elektromechanischen aktuatoren | |
ATE289604T1 (de) | Neue phenylpiperazine | |
DE60226256D1 (de) | Chronographen-mechanismus | |
DE50309081D1 (de) | Neue diketopyrrolopyrrolpigmente | |
DE60216986D1 (de) | Neue verwendung von pipatalin | |
DE60206043D1 (de) | Neue indolderivate | |
DE60211158D1 (de) | Neue verwendung von cyclodextrineinschlusskomplexen | |
DE50205590D1 (de) | Ummantelung von leiterbahnen | |
NO20014168D0 (no) | Ballastvannutskifting | |
DE60112036D1 (de) | Uhrwerk | |
DE10294298D2 (de) | Plektron | |
FI20010391A0 (fi) | Kalanteri | |
DE60233601D1 (de) | Verwendung von bestimmten Cyclolignanen | |
DE60233952D1 (de) | Neue serinprotease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1427724 Country of ref document: EP |